Cargando…

Kinase insert domain receptor/vascular endothelial growth factor receptor 2 (KDR) genetic variation is associated with ovarian hyperstimulation syndrome

BACKGROUND: The objective of this investigation was to determine if kinase insert domain/vascular endothelial growth factor receptor 2 (KDR/VEGFR2) genetic variation was associated with the development of ovarian hyperstimulation syndrome (OHSS) in patients undergoing controlled ovarian hyperstimula...

Descripción completa

Detalles Bibliográficos
Autores principales:	O’Brien, Travis J, Harralson, Arthur F, Tran, Tuyen, Gindoff, Ian, Orkunoglu-Suer, Funda E, Frankfurter, David, Gindoff, Paul
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2014
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4024119/ https://www.ncbi.nlm.nih.gov/pubmed/24886133 http://dx.doi.org/10.1186/1477-7827-12-36

Ejemplares similares

Targeted single molecule sequencing methodology for ovarian hyperstimulation syndrome
por: Orkunoglu-Suer, Funda, et al.
Publicado: (2015)

Association between the luteinizing hormone/chorionic gonadotropin receptor (LHCGR) rs4073366 polymorphism and ovarian hyperstimulation syndrome during controlled ovarian hyperstimulation
por: O’Brien, Travis J, et al.
Publicado: (2013)

Association of kinase insert domain-containing receptor (KDR) gene polymorphism/ haplotypes with recurrent spontaneous abortion and genetic structure
por: Shahsavari, Shiva, et al.
Publicado: (2015)

Amino substituted nitrogen heterocycle ureas as kinase insert domain containing receptor (KDR) inhibitors: Performance of structure–activity relationship approaches
por: Yilmaz, Hayriye, et al.
Publicado: (2015)

Pyrrolo[3,2-d]pyrimidine Derivatives as Type II Kinase Insert Domain Receptor (KDR) Inhibitors: CoMFA and CoMSIA Studies
por: Wu, Xiao-Yun, et al.
Publicado: (2012)

Nephrotic Sydrome Developing in Severe Ovarian Hyperstimulation Syndrome
por: Gungor Ugurlucan, Funda, et al.
Publicado: (2014)

Race and Drug Toxicity: A Study of Three Cardiovascular Drugs with Strong Pharmacogenetic Recommendations
por: O’Brien, Travis J., et al.
Publicado: (2021)

Ovarian hyperstimulation syndrome
por: Kumar, Pratap, et al.
Publicado: (2011)

Ovarian and intellectual hyperstimulation
por: Quaas, Alexander M.
Publicado: (2021)

Rare variants in KDR, encoding VEGF Receptor 2, are associated with tetralogy of Fallot
por: Škorić-Milosavljević, Doris, et al.
Publicado: (2021)

The investigation of cholinergic receptor muscarinic 1 activity in the rat ovary with induced ovarian hyperstimulation
por: Şanlı, Cengiz, et al.
Publicado: (2023)

Role of VEGF signalling in the regulation of KDR expression in endothelial and tumoral microenvironment
por: Serpa, Jacinta, et al.
Publicado: (2010)

The related FLT4, FLT1, and KDR receptor tyrosine kinases show distinct expression patterns in human fetal endothelial cells
Publicado: (1993)

Correction to: Rare variants in KDR, encoding VEGF Receptor 2, are associated with tetralogy of Fallot
por: Škorić-Milosavljević, Doris, et al.
Publicado: (2021)

Spontaneous Ovarian Hyperstimulation Syndrome with FSH Receptor Gene Mutation: Two Rare Case Reports
por: Topdagi Yilmaz, Emsal Pinar, et al.
Publicado: (2018)

Transient receptor potential melastatin 2 ion channel activity in ovarian hyperstimulation syndrome physiopathology
por: ŞANLI, Cengiz, et al.
Publicado: (2021)

Early onset ovarian hyperstimulation syndrome despite use of segmentation approach and ovarian hyperstimulation syndrome prophylaxis
por: Mahajan, Nalini, et al.
Publicado: (2015)

The Impact of Kinase Insert Domain (KDR) Gene Polymorphism rs2305948 on Clopidogrel Resistance in Iraqi Patients Undergoing Elective Percutaneous Coronary Intervention (PCI)
por: Ahmed, Ali A., et al.
Publicado: (2020)

Investigating the association between polymorphism of follicle-stimulating hormone receptor gene and ovarian response in controlled ovarian hyperstimulation
por: Sheikhha, Mohammad Hasan, et al.
Publicado: (2011)

Molecular Analysis of a Mutated FSH Receptor Detected in a Patient with Spontaneous Ovarian Hyperstimulation Syndrome
por: Uchida, Sayaka, et al.
Publicado: (2013)

Novel FSH receptor mutation in a case of spontaneous ovarian hyperstimulation syndrome with successful pregnancy outcome
por: Chauhan, Anahita R., et al.
Publicado: (2015)

Ovarian Hyperstimulation Syndrome, the Master of Disguise?
por: Ironside, Emily Charlotte, et al.
Publicado: (2015)

Liver progenitor cell and KDR
por: Han, Songyan, et al.
Publicado: (2014)

Novel hKDR mouse model depicts the antiangiogenesis and apoptosis‐promoting effects of neutralizing antibodies targeting vascular endothelial growth factor receptor 2
por: Cao, Yuan, et al.
Publicado: (2022)

Therapeutic siRNA targeting endothelial KDR decreases portosystemic collateralization in portal hypertension
por: Gallego, Javier, et al.
Publicado: (2017)

The Effectiveness of Cabergoline for the Prevention of Ovarian Hyperstimulation Syndrome
por: Hosseini, Marzieh Agha, et al.
Publicado: (2011)

Ovarian Hyperstimulation Syndrome as an Etiology of Obstructive Uropathy
por: Marak, Creticus P., et al.
Publicado: (2013)

Radiological Illustration of Spontaneous Ovarian Hyperstimulation Syndrome
por: Mittal, Kartik, et al.
Publicado: (2015)

Prevention of Ovarian Hyperstimulation Syndrome: A Review
por: Smith, Vinayak, et al.
Publicado: (2015)

Zika virus during controlled ovarian hyperstimulation
por: Joob, Beuy, et al.
Publicado: (2019)

Immunoglobulin Treatment in Severe Ovarian Hyperstimulation Syndrome
por: Gómez, Gemma Grau, et al.
Publicado: (2019)

Persistent ascites resolving with gonadotropin-releasing-hormone-agonist 18 months after hospitalization for severe ovarian hyperstimulation syndrome
por: Comba, Cihan, et al.
Publicado: (2013)

Multidimensional Proteomic Approach of Endothelial Progenitors Demonstrate Expression of KDR Restricted to CD19 Cells
por: Guerin, Coralie L., et al.
Publicado: (2020)

Insertion and internalization of acetylcholine receptors at clustered and diffuse domains on cultured myotubes
Publicado: (1985)

Evolution of kdr haplotypes in worldwide populations of Aedes aegypti: Independent origins of the F1534C kdr mutation
por: Cosme, Luciano Veiga, et al.
Publicado: (2020)

Polymorphisms of VEGF and VEGF receptors are associated with the occurrence of ovarian hyperstimulation syndrome (OHSS)—a retrospective case–control study
por: Nouri, Kazem, et al.
Publicado: (2014)

Severe ovarian hyperstimulation syndrome and gonadotropin-releasing hormone agonist trigger in patients with hypogonadotropic hypogonadism: A report of two cases
por: Gürbüz, Ali Sami, et al.
Publicado: (2020)

Breast tumors induce the recruitment of AC133(+)KDR(+ )endothelial precursor cells mobilized by plasma vascular endothelial growth factor
por: Botelho, M, et al.
Publicado: (2005)

Calcium gluconate infusion is as effective as the vascular endothelial growth factor antagonist cabergoline for the prevention of ovarian hyperstimulation syndrome
por: Naredi, Nikita, et al.
Publicado: (2013)

Ovarian hyperstimulation syndrome (OHSS) at a maternity hospital
por: Lappas, V, et al.
Publicado: (1999)

Cannot write session to /tmp/vufind_sessions/sess_0a1cvsob3qb71ive5hd3lhorqu